Boston Scientific: Data backs Boston Scientific drug-eluting stent

Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD. The company shared multiple new clinical data sets at Charing Cross 2025 in London today. Findings reinforced the growing body of evidence supporting the Eluvia stent for treating peripheral artery disease (PAD) - particularly in the superficial femoral [...]The post Data backs Boston Scientific drug-eluting stent appeared first on Drug Delivery Business.